The efficient conversion of solar energy into storable forms of chemical energy is the dream of many engineers. Nature found ...
Kim Kelderman; Chief Executive Officer, Chief Operating Officer, Director; Bio-Techne Corp James Hippel; Chief Financial Officer, Executive Vice President - Finance; Bio-Techne Corp Good morning, and ...
Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2025. At this time, all participants have been placed in a listen-only mode and the call will ...
LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded ...
Photosynthesis -- mainly carried out by plants -- is based on a remarkably efficient energy conversion process. To generate chemical energy, sunlight must first be captured and transported further.
Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on ...
Hosted on MSN6d
TECH Gears Up to Report Q2 Earnings: Here's What to ExpectBio-Techne Corporation TECH is set to release its second-quarter fiscal 2025 results on Feb. 5, before the opening bell. Find ...
A fungus named in honor of Sir David Attenborough is warping the bodies and even minds of spiders in Ireland. Researchers ...
Detailed price information for Lifevantage Corp (LFVN-Q) from The Globe and Mail including charting and trades.
Gross profit for the second quarter of fiscal 2025 was $54.6 million, or 80.5% of revenue, compared to $40.6 million, or 78.6% of revenue, for the same period in fiscal 2024. The increase in gross ...
A study from the Technical University of Munich (TUM) highlights the role of quantum mechanics in photosynthesis, a process ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback